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CONCLUSIONS AND DISCUSSION
This thesis contains five clinical studies concerning ditl 'erent aspects of the trcat-
ment of extremity melanonra. In the fbllowing sections the results of thesc studies
are discussed.
GROIN DISSECTION IN THE TREATMENT OF EXTREMITY
MELANOMA
The evaluation of the results of the Groningen technique of 
-eroin dissection in
patients with lower extremity melanoma as described in chapter 2 has the known
disadvantages of any retrospective stud),. In this stuily we describe our conrplica-
tiorrs atter groin dissection.
The results show no local recumence of lymph node metastases, which rnakes
this technique of groin dissc-ction oncologically sound. In J6(/t of patient\ prirnrrrl
u'ound closure and primlry healing were accolnplished. In nlost other techniques
using excision of skin over the lymph nodes. tr free skin erafi is necessa-
ry37.-18.'10. Theresults further show that groin dissecticln in combination with isola-
tecl regional perfusion does not have an evident negative ef'fbct on wountl healing.
Ederna is a frequently clescribed conrplication. We tried to gain more insight into
the relation between the rate of edema and functional disorder. The classification
clf the rate of edema we used in this study is l practical one and can be rccorr-
mended fbr future studies. The classification of SchmidtkeTI rnul be nrore lational
on theoretical grounds. it is not a practical one and depends on the investigator.
Only 3 patients with moclerate or severe edema. out of a eroup of 66 patients hacl
functional disorders of the treated le-t due to edema. Theretore. the conclusion is
waranted that with this technique of groin dissection functional disorder clue tcr
edenra is  a minor  problem.
In summary. this technique of 
-orclin dissection is simple. oncologically sound.
causes only minimal morbidity and gives good short-term and long-term results.
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REGIONAL PERFUSION IN LOCORE(;IONALLY METASTASIZF]I)
EXTREMITY MELANOMA
Thc results presented in chapter 3 show lowcr survival and disease-frec survival
rates in aclvancing sta-ses II. IIIA and IIIAB according to the classification system
of the MD Anderson Hospital. A lO-year overall survival of 63c/, was fbund in
stage Il. This is ir.t nccordance with a comparable stucly by Krementz et ul.5l. who
firuncl a l0-year survival of 5l(/,. In stage IIIA patients the l0-year overall survi-
val was'15%. Sutherland et al.7l reported in a recent study on regional perfusion
irr the treatment of extremity melanoma a l0-year survival of 33%. whereas Shir.r
et aI.73 lbuncl a 5-year survival of 50% when using rnechlorethatnine (nitrogen
r.nustard) as cytostatic. The l0-year survival in sta-se IIIAB patients was 347r,,
corlparable with both Sutherland et trl.72 and Hartley et al.7'1 who lbund in similar
perl 'usion studies a l0-year survival of 29c/r'. Local recurrence was mainly seen
within the first 3 years afier treatment with regional perfusion. The overall survi-
val rnd disease-fice survival rates of rcgional perfusion of the lower e xtrernity
e xceed the results of rcgional perfusion of thc upper extremity. In this stucly. how-
ever, the group of patienls with an arm perfusion is small. ancl variables such as
scx ancl stage are not inclucied.
A distinction firr stage is made tbr the groups of patients who underwent one or
two perl 'usions. This study shows no evidence that a second perfusion adcls to the
treatmcnt. Moreover, because the cornplication risk increases with a second perfu-
sion5r. the two-perfusion regimen fbr locoregionally metastasized exfrernity
rnelanoma should only be used in carefully selected patients.
According to the results of the study described in chapter 4. the best results in
the treatment of locoregional metastases of lower extrernity melanoma are a-
chieved with hypertherrnic regional perfusion using a combination of melphalan
anci clactinomycin. with the melphnlan dose calculated on the basis of the volume
of' the atl 'ectecl leg and the dactinomycin dose on the basis of bocly weight.
Although the diff-erences in thc difterent treatecl groups were significant
1p < 0,05). one must note the small nuntber of patients, especially in the group
who had becn given melphalan on the basis of the volume of the affected leg.
Also, variables uch as sex. site and stage were not rnatched. In view of thc known
bettcr prognosis of extremity rnelanomas in f 'emales ancl the worse prognosis of
foot melanoma. those variables may influence the results. As tbr the stage. only
stage IIIA could be analysed because in the other stages thc number of patients
was too smal l . ' fhe analys is  in  th is  s tage show the same tendencv as the overal l
eroup results. Vrriables such as operative technique. composition of the perfusate
and nrode of aclninistration of the cytostatic do not vary in this stucly. The extent
to which increasec'l experience and the use of higher flow l 'ates cluring perfusion
influence the results in this stuil l , is unkno'nvn.
In summary, the finclin-es of this study shorv a tenclencv of irnproving treatment
results in tinre. possibly on the basis of the chan-eed c'n,tostatic re-rimen. Further
studies u,i l l  be needecl to establish the optin.ral treatmenl resimen lor isolated
regional perfusion in the treatment of locallv r-netastasized melanonra of the ertre-
nr it1,.
REGIONAL PERFUSION IN SUBUNGT]AL MELANOMA AND IN
MELANONIA IN CHILDREN
Treatment of sutrun-qual melanoma ivith arnputation and acl.juvant isolateci re.tir 'rnal
perfusion did not improve survival in the small number of patienfs vn'e valuated as
compared with other sludisqb0-6).7-5.76. Howe\/er, substantial pall iation was a-
chievecl because no instances of local or regional recurrence were observed. Sincc
th is  s tuc ly  shows excel lent  locoregional  contro l  wi th no s igni f icant  increar t ' i t t
rnorbiclity. adjuvant regional perfusion in the treatnrent of subungual melanonta
seems t() be inclicated.
As fbr subungual melanorna. nrelanornas in children are rare and thercfole l
prospective randornized trial is inipossible. In this stucll 'regional perfusion in thr'
treatment of extremitl, urelanoma seems a saf'e treatrnent moclality in children.
because no growth disturbances or other major cornplications werc seen. In this
study the overall survival rate is high and the local recurrence rate is lor.r 'conrpa-
red with the f 'ew other studies in thic fie1d63.61.66.
Sincc the treatnrent strategy fbr extrernity rnelanonra in children i incl adults dms
not clif ' fer6e. and the expectecl risk of growth disturbances do not seertr to plav ln
important role, regional perfusirx should have the strnre place in the treatrnent ol
extremity rnelanor.na in children as in adults.
